| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13186* | 2021 |
| DrugBank 5.0: a major update to the DrugBank database for 2018 DS Wishart, YD Feunang, AC Guo, EJ Lo, A Marcu, JR Grant, T Sajed, ... Nucleic acids research 46 (D1), D1074-D1082, 2018 | 6878 | 2018 |
| Head and neck squamous cell carcinoma DE Johnson, B Burtness, CR Leemans, VWY Lui, JE Bauman, JR Grandis Nature reviews Disease primers 6 (1), 92, 2020 | 2398 | 2020 |
| Targeting the IL-6/JAK/STAT3 signalling axis in cancer DE Johnson, RA O'Keefe, JR Grandis Nature reviews Clinical oncology 15 (4), 234-248, 2018 | 2171 | 2018 |
| Structural and functional diversity in the FGF receptor multigene family DE Johnson, LT Williams Advances in cancer research 60, 1-41, 1992 | 1675 | 1992 |
| Signalling by receptor tyrosine kinases WJ Fantl, DE Johnson, LT Williams Annual review of biochemistry 62 (1), 453-481, 1993 | 1408 | 1993 |
| Expression and structure of the human NGF receptor D Johnson, A Lanahan, CR Buck, A Sehgal, C Morgan, E Mercer, ... Cell 47 (4), 545-554, 1986 | 1293 | 1986 |
| Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo JR Grandis, SD Drenning, Q Zeng, SC Watkins, MF Melhem, S Endo, ... Proceedings of the National Academy of Sciences 97 (8), 4227-4232, 2000 | 840 | 2000 |
| Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor PL Lee, DE Johnson, LS Cousens, VA Fried, LT Williams Science 245 (4913), 57-60, 1989 | 818 | 1989 |
| Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. K Keegan, DE Johnson, LT Williams, MJ Hayman Proceedings of the National Academy of Sciences 88 (4), 1095-1099, 1991 | 550 | 1991 |
| The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third … DE Johnson, J Lu, H Chen, S Werner, LT Williams Molecular and cellular biology, 1991 | 507 | 1991 |
| Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth PL Leong, GA Andrews, DE Johnson, KF Dyer, S Xi, JC Mai, PD Robbins, ... Proceedings of the National Academy of Sciences 100 (7), 4138-4143, 2003 | 505 | 2003 |
| Diverse forms of a receptor for acidic and basic fibroblast growth factors DE Johnson, PL Lee, J Lu, LT Williams Molecular and cellular biology 10 (9), 4728-4736, 1990 | 477 | 1990 |
| Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities S Werner, DSR Duan, C De Vries, KG Peters, DE Johnson, LT Williams Molecular and cellular biology 12 (1), 82-88, 1992 | 407 | 1992 |
| Noncaspase proteases in apoptosis DE Johnson Leukemia 14 (9), 1695-1703, 2000 | 369 | 2000 |
| Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells A Herman-Antosiewicz, DE Johnson, SV Singh Cancer research 66 (11), 5828-5835, 2006 | 353 | 2006 |
| Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2 D Xiao, S Choi, DE Johnson, VG Vogel, CS Johnson, DL Trump, YJ Lee, ... Oncogene 23 (33), 5594-5606, 2004 | 322 | 2004 |
| First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy M Sen, SM Thomas, S Kim, JI Yeh, RL Ferris, JT Johnson, U Duvvuri, ... Cancer discovery 2 (8), 694-705, 2012 | 319 | 2012 |
| Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis EP Sampaio, AP Hsu, J Pechacek, HI Bax, DL Dias, ML Paulson, ... Journal of allergy and clinical immunology 131 (6), 1624-1634. e17, 2013 | 249 | 2013 |
| (−)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-XL-mediated apoptosis resistance CL Oliver, MB Miranda, S Shangary, S Land, S Wang, DE Johnson Molecular cancer therapeutics 4 (1), 23-31, 2005 | 241 | 2005 |
